Omalizumab treats multi-food allergy better than oral immunotherapy, study finds
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small amounts of common food ...
Mar 2, 2025
0
1